Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of perioperative changes of blood coagulation factors in patients with left ventricular assist device implantation and impact of XIII factors in postoperative hemostasis after LVAD implantation

Trial Profile

Evaluation of perioperative changes of blood coagulation factors in patients with left ventricular assist device implantation and impact of XIII factors in postoperative hemostasis after LVAD implantation

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 25 Aug 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Factor XIII (Primary)
  • Indications Blood coagulation disorders
  • Focus Adverse reactions

Most Recent Events

  • 17 Aug 2020 Status changed from active, no longer recruiting to discontinued.
  • 07 May 2019 Status changed from recruiting to active, no longer recruiting.
  • 01 Jul 2017 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top